Perspectivas del mercado y visión del analista:
El pronóstico del mercado de informática para el descubrimiento de fármacos se deriva de los hallazgos de varios estudios secundarios y fuentes primarias de investigación.
La informática para el descubrimiento de fármacos es un campo que integra las ciencias computacionales y de la información con la química y la biología. Utiliza diversas herramientas computacionales, algoritmos y bases de datos para estudiar e interpretar grandes volúmenes de datos biológicos y químicos. Al utilizar el poder de la informática, los investigadores pueden acelerar el proceso de descubrimiento de fármacos, lo que da como resultado una identificación de posibles fármacos candidatos de forma más eficiente y rentable. Por lo tanto, la adopción de herramientas informáticas está contribuyendo al creciente tamaño del mercado de la informática para el descubrimiento de fármacos.
Impulsores que afectan el crecimiento del mercado de la informática para el descubrimiento de fármacos
Las industrias farmacéutica y biofarmacéutica invierten fuertemente en I+D para desarrollar nuevos productos y ampliar la cartera de productos en áreas como inmunología, cáncer y enfermedades infecciosas. Por ejemplo, muchas empresas farmacéuticas innovadoras están invirtiendo ahora en genómica para revitalizar el descubrimiento de fármacos. Según el artículo publicado por el Journal of Precision Medicine en marzo de 2021, AstraZeneca lanzó un proyecto para secuenciar 2 millones de genomas, una iniciativa masiva destinada a recopilar secuencias de genomas y registros médicos durante la próxima década. La misma fuente afirmó además que GlaxoSmithKline invirtió £40 (UD$ 42,48) millones para ampliar su asociación con el Biobanco del Reino Unido. Esta inversión apoya la secuenciación de 500.000 personas, generando un recurso de datos excepcionalmente rico que es a la vez anónimo y seguro. En lugar de obtener datos, las principales empresas farmacéuticas están aprovechando conjuntos de datos poblacionales ricos en datos genómicos, fenotípicos y clínicos. Por lo tanto, las crecientes inversiones en actividades centradas en el descubrimiento de fármacos están impulsando el crecimiento del mercado de la informática para el descubrimiento de fármacos.
Perspectivas estratégicas
Segmentación y alcance del informe:
El "descubrimiento global de fármacos" Análisis del mercado de informática hasta 2031" es un estudio especializado y en profundidad que se centra en la dinámica del mercado global para ayudar a identificar los factores impulsores clave, las tendencias futuras y las oportunidades lucrativas que, a su vez, ayudarían a identificar las principales fuentes de ingresos. El informe tiene como objetivo proporcionar una descripción general del mercado con una segmentación detallada del mercado por flujo de trabajo, servicios, soluciones y usuario final. El alcance del informe del mercado de informática para el descubrimiento de fármacos abarca América del Norte (EE. UU., Canadá y México), Europa (España, Reino Unido, Alemania, Francia, Italia y el resto de Europa), Asia Pacífico (Corea del Sur, China, India, Japón, Australia y el resto de Asia Pacífico), Medio Oriente y África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de Asia Pacífico). Resto de América Central y del Sur).
Análisis segmentario:
Por flujo de trabajo, el mercado se bifurca en informática de descubrimiento y desarrollo de fármacos. El segmento de informática de descubrimiento tuvo una mayor participación de mercado en 2023. Se proyecta que el segmento de desarrollo de fármacos registre una CAGR más alta de 2023 a 2031.
El mercado, por servicio, se segmenta en plataformas de análisis de secuencia, modelado molecular, gestión de datos de ensayos clínicos, acoplamiento y otros. Se prevé que el segmento de plataforma de análisis de secuencia tenga la mayor cuota de mercado de informática para el descubrimiento de fármacos en 2023. Se prevé que el segmento de modelado molecular registre la CAGR más alta de 2023 a 2031.
Por solución, el mercado de informática para el descubrimiento de fármacos es segmentados en software y servicios. El segmento de servicios tuvo una mayor participación de mercado en 2023, y se proyecta que el mismo segmento registre una CAGR más alta de 2023 a 2031.
Mercado de informática de descubrimiento de fármacos por solución: 2023 y 2031
Basado en En cuanto al usuario final, el mercado está segmentado en empresas farmacéuticas y de biotecnología, organizaciones de investigación por contrato y otras. El segmento de empresas farmacéuticas y de biotecnología tuvo la mayor participación del mercado en 2023. Se espera que el segmento de organizaciones de investigación por contrato registre la CAGR más alta de 2023 a 2031.
Perspectivas regionales:
América del Norte tuvo la mayor cuota de mercado de informática para el descubrimiento de fármacos en 2023. Estados Unidos tenía la mayor cuota de mercado en 2023, seguido de Canadá. Esto se atribuye a factores como la presencia de actores importantes, incluidos Charles River Laboratories, Certara y Curia, la alta incidencia de enfermedades infecciosas y la rápida adopción de herramientas de I+D nuevas y avanzadas por parte de las principales empresas farmacéuticas y organizaciones de investigación por contrato (CRO). ) para el descubrimiento y desarrollo de fármacos. Estas empresas se están centrando cada vez más en empresas conjuntas y colaboraciones de investigación, que se espera que impulsen aún más el crecimiento del mercado en la región. Por ejemplo, en agosto de 2022, Atomwise inició una colaboración de investigación estratégica de múltiples objetivos con Sanofi para el descubrimiento de fármacos impulsados por IA. La colaboración se centrará en aprovechar la plataforma AtomNet de la empresa para hasta cinco objetivos farmacológicos como parte de sus esfuerzos de investigación y descubrimiento computacional.
Desarrollos de la industria y oportunidades futuras:
Según los comunicados de prensa de la empresa, A continuación se enumeran algunas iniciativas tomadas por actores clave que operan en el mercado global de informática para el descubrimiento de fármacos:
•En enero de 2024, Evotec se asoció con la Fundación Crohn's & Colitis para desarrollar nuevos tratamientos para la enfermedad inflamatoria intestinal (EII). ). En el marco de esta asociación, ambas empresas utilizarán la plataforma integral de investigación y desarrollo de Evotec para avanzar en el descubrimiento de fármacos para dos objetivos farmacológicos innovadores que abordan la fibrosis y la función de barrera intestinal deteriorada. En noviembre de 2023, Certara presentó el software Simcyp Biopharmaceutics, cuyo objetivo es aumentar la eficiencia de Desarrollo de formulaciones para medicamentos nuevos y genéricos. El software Simcyp Biopharmaceutics está diseñado para ayudar a los biofarmacéuticos, formuladores y científicos a formular de forma rápida y rentable medicamentos de molécula pequeña complejos, novedosos y genéricos. En junio de 2022, Chemical.AI y Chemaxon anunciaron una colaboración para integrar sus conocimientos científicos. software de informatica. Chemical.AI, una reconocida firma de Inteligencia Artificial (IA), anunció una asociación estratégica con Chemaxon, una empresa líder en desarrollo de software químico y biológico. La colaboración permite a los usuarios finales acceder a Design Hub de Chemaxon y a ChemAIRS de Chemical.AI como opción. En abril de 2022, Certara, Inc. y Chemaxon firmaron una asociación estratégica para modernizar la investigación farmacéutica. La asociación proporciona interconectividad entre sus flujos de trabajo de informática científica. El software Scientific Informatics de Certara se conectará perfectamente con Design Hub de Chemaxon, proporcionando a los usuarios análisis y diseño de compuestos. Este desarrollo conjunto se basa en integraciones entre los productos Certara y Chemaxon, como el cartucho químico JChem, MarvinSketch y JChem para Office. Panorama competitivo y empresas clave:
Certara; Infosys Ltd.; Descubrimiento colaborativo de fármacos, Inc.; Biosis Jubliant; Curia Global, Inc.; Chemaxon Ltd; Laboratorios Charles River; Tecnologías Agilent, Inc.; Illumina, Inc; Boehringer Ingelheim International GmbH; y Evotec se encuentran entre las empresas destacadas descritas en el informe del mercado de informática para el descubrimiento de fármacos. Estas empresas se centran en nuevas tecnologías, avances de productos existentes y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The drug discovery informatics market, by workflow, is bifurcated into discovery informatics and drug development. The discovery informatics segment held a larger market share in 2023.
The drug discovery informatics was valued at US$ 3.073billion in 2023.
The drug discovery informatics is expected to be valued at US$ 8.17 billion in 2031.
The drug discovery informatics majorly consists of the players, including Certara; Infosys Ltd.; Collaborative Drug Discovery, Inc.; Jubliant Biosys; Curia Global, Inc.; Chemaxon Ltd; Charles River Laboratories; Agilent Technologies, Inc.; Illumina, Inc; Boehringer Ingelheim International GmbH; and Evotec.
Key factors driving the drug discovery informatics growth are the increasing investments in the R&D of new drug molecules by pharmaceutical companies and the growing adoption of computational and information tools for drug discovery and development.
Drug discovery informatics is a field that integrates computational and information sciences with chemistry and biology. It uses various computational tools, algorithms, and databases to study and interpret vast volumes of biological and chemical data.
The List of Companies - Drug Discovery Informatics Market
- Certara
- Infosys Ltd.
- Collaborative Drug Discovery, Inc.
- Jubliant Biosys
- Curia Global, Inc.
- Chemaxon Ltd
- Charles River Laboratories
- Agilent Technologies, Inc.
- Illumina, Inc
- Boehringer Ingelheim International GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2024
Emergency Call Systems Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Fall Prevention and Detection, Workflow Optimization, Patient Care Reminders, Alarms and Communication Management, Wander Management, Reporting and Analytics, Real-Time Staff Locating, and Others), End User (Hospital and Clinics, Assisted Living and Independent Living Facilities, Ambulatory Surgical Centers, and Others), Technology (Wired and Wireless), Offering (Hardware, Software, and Services), Product Type (Nurse Call Systems, Call Box Systems, Emergency Stanchions, Intercom System, and Others),, and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Outpatient Central Fulfillment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2024
Well-Being Platform Market
Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
Mar 2024
Product Design and Development Services Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Services (Research, Strategy, and Concept Generation; Concept and Requirement Development; Detailed Design and Process Development; Process Validation, Manufacturing Transfer, and Design Validation; and Other Services), Application (Diagnostic Equipment, Therapeutic Equipment, Surgical Instruments, Clinical Laboratory Equipment, Biological Storage, Consumables, and Others), and End User (Medical Companies, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations)
Mar 2024
Patient Engagement Technology Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Services, Hardware, and Software), Therapeutic Area (Fitness, Chronic Diseases, Women’s Health, and others), Delivery Mode (Cloud-Based and On-Premises), Application (Health Management, Financial Health Management, Home Healthcare Management, and Others), and End User (Patients, Payers, Providers, and Others)
Mar 2024
IVD Contract Research Organization Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
Mar 2024
Dental CAD/CAM Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Dental CAD/CAM Materials (Glass Ceramics, Alumina-Based Ceramics, Lithium Disilicate, Zirconia, and Others) and Dental CAD/CAM Systems], Type (In-Office Systems and In-Lab Systems), Components [Hardware (Dental Printers, Milling Machines, Scanners, and Others) and Software], Application (Dental Prosthesis, Dental Implants, and Others), and End User (Dental Clinics, Dental Laboratories, Milling Centers, and Others)
Mar 2024
Emergency Medical Software Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Early Warning and Vulnerability Alert System (EWVAS), EMS Computer Aided Dispatch (CAD) System, Incident Response Software, Ambulance Management Software, and Others], Mode of Delivery [On Premises and Software as a Service (SaaS)], Platform (Android, iOS, Windows, and Others), and End User (Commercial, Municipal, State City Agencies, and Others)